Josh Copp is senior vice president, global products and services at Vantive. In this role, Copp oversees Vantive’s global portfolio strategy and execution, driving new product development, launch, commercial optimization, lifecycle management and service excellence.
Copp brings deep experience across the healthcare and medical technology sectors, spanning global strategy, commercial execution, innovation, market access and digital transformation. Most recently, he served as chief business officer at Ceribell, where he led clinical sales, reimbursement, and marketing and portfolio launch strategy for a rapidly scaling medical device company. Prior to Ceribell, Copp was a partner at McKinsey and Company, where he advised leading medical technology companies on growth strategy, commercial transformation, digital strategy, innovation portfolio management and mergers and acquisitions. He also co-led McKinsey’s Digital and Analytics practice for Medical Products globally.
Copp received a bachelor’s degree in applied mathematics from Harvard University and a master’s degree in business administration from the Massachusetts Institute of Technology Sloan School of Management.
Asia Pacific
North America
